Strengthening Overseas Business Through Region-Specific Expansion, Development and Withdrawal
First written in FY2020. 7 of 10 entries say "Advanced", first in FY2021. Latest entry: FY2026.
1 other company's latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The Group aims to establish a development, production and sales structure based on local production for local consumption. On the development side, it established a new North American R&D center site in San Francisco, while on the production side it launched a production facility for turbomolecular pumps in China.」
Strengthening the overseas business has taken concrete form through the development of regional markets, development in North America, production in China, and the establishment of a local-for-local structure through the integration of sales systems in India and Australia. - FY2025AdvancedAnnual report
「③ In India, the company will establish an integrated company handling analytical and medical products and develop customer-focused sales activities. It will also proceed with construction of a plant scheduled to begin operations in 2027.」
The expansion of overseas operations included concrete plans to establish an analytical and medical integrated company in India and construct a plant scheduled to begin operations in 2027. - FY2025-H1AdvancedAnnual report
「To expand overseas operations, we established an R&D center in North America and a sales subsidiary for analytical and medical equipment in Mexico,」
Expansion of overseas business took concrete form through the establishment of a North American R&D center and a Mexican sales subsidiary, strengthening the regional base and sales structure. - FY2024AdvancedAnnual report
「In the overseas business, efforts to resolve issues together with partners resulted in higher sales in all major regions. The overseas sales ratio rose to 56.2%, up 3.2 percentage points from the previous fiscal year.」
The overseas business posted higher revenue in all major regions, and the overseas sales ratio rose to 56.2%. The results for the full year demonstrated the benefits of the regional base and partner strategy, including the North America R&D center. - FY2024-Q3RestatedAnnual report
「The measuring instruments business posted higher sales both in Japan and overseas.」
Revenue growth in both domestic and overseas businesses, including the measuring instruments business, has continued. By major region, revenue increased in Europe, China and other parts of Asia. - FY2023AdvancedAnnual report
「In the overseas business, efforts to resolve issues together with partners resulted in higher sales in all major regions. The overseas sales ratio rose to 56.2%, up 3.2 percentage points from the previous fiscal year.」
Concrete progress has been shown in strengthening overseas operations in line with regional characteristics, with higher sales in all major regions and overseas sales accounting for 56.2%. - FY2023-Q1RestatedAnnual report
「Sales increased as Europe and other parts of Asia remained firm, along with the impact of foreign exchange movements and other factors.」
The company has reaffirmed that overseas business sales increased against a backdrop of solid performance in Europe and other parts of Asia, as well as foreign exchange effects. - FY2022AdvancedAnnual report
「In the overseas business, efforts to address challenges together with global partners resulted in higher sales in all major regions, and the overseas sales ratio rose to 53.0%, up 2.2 percentage points year on year.」
Overseas operations reported higher revenue in all major regions, and the overseas revenue ratio rose 2.2 percentage points to 53.0%. - FY2021AdvancedAnnual report
「To achieve business growth overseas, the company will strengthen the functions of its innovation centers in line with regional demand, focusing on pharmaceuticals in the United States and clinical applications in Europe, among other initiatives, and develop solutions for strong regional industries jointly with leading partners. It will also deploy the solutions it develops globally to create a virtuous cycle of growth.」
The priority markets by region, innovation centers, joint development with leading partners and the global rollout of development solutions have taken concrete form. - FY2020First statedAnnual report
「To achieve overseas business growth, we will strengthen the capabilities of key sites and promote business growth in collaboration with strong industries and customers in each region. Taking regional business characteristics into account, we will distinguish among businesses to expand, develop, or exit, and aim to increase the overseas sales ratio through disciplined investment.」
A new overseas strategy was presented involving stronger key sites, collaboration with regional industries and customers, selective expansion, development, or exit of businesses, and disciplined investment to increase the overseas sales ratio.